Seller record · Telehealth service

Omnia TeleHealth

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S4, compounding disclosure: No page states that compounded products are not FDA-approved. The weight loss page offers compounded versions through the partner pharmacy beside a description of semaglutide and tirzepatide under their brand names. 2 more criteria also fail; see the table below.

At a glance

Omnia TeleHealthTelehealth service

5/8criteria passed

Price: Not printed before a consultation or sign-up
Sells: compounded semaglutide, compounded tirzepatide, and 2 more
FDA letters: None on file

Visit Omnia TeleHealth See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

An Alabama nurse-practitioner-led telehealth practice treating more than 70 conditions in 17 states, whose weight loss service prescribes semaglutide or tirzepatide after a flat-fee virtual consultation, with compounded versions filled by a named partner pharmacy.

Operating entity No legal entity name appears in the footer, on the about or contact pages or in the privacy policy, which name the business only as Omnia TeleHealth.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Omnia TeleHealth's for weight loss page; Omnia TeleHealth's about page
S2	Prescription gating	PASS	Omnia TeleHealth's website; Omnia TeleHealth's for weight loss page
S3	Pharmacy identification	PASS	Omnia TeleHealth's for weight loss page; Omnia TeleHealth's privacy policy
S4	Compounding disclosure	FAIL	Omnia TeleHealth's for weight loss page
S5	Analytical documentation	FAIL	Omnia TeleHealth's for weight loss page; Omnia TeleHealth's weight loss refill page; Omnia TeleHealth's about page
S6	Business address	PASS	Omnia TeleHealth's contact page; Omnia TeleHealth's privacy policy
S7	Price disclosure	FAIL	Omnia TeleHealth's for weight loss page; Omnia TeleHealth's website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed provider evaluates each patient's eligibility in a virtual consultation before prescribing semaglutide or tirzepatide, and the pages name the founder and primary provider, Blair Carmichael-Lober, DNP, CRNP.Source: Omnia TeleHealth's for weight loss page; Omnia TeleHealth's about page.

S2PASSThe steps list choosing a service, then a visit form with symptoms and medical history, then care from a licensed provider, and the flat $69 weight loss visit pays for that consultation.Source: Omnia TeleHealth's website; Omnia TeleHealth's for weight loss page.

S3PASSThe footer of every page names the partner pharmacy, Belmar Pharma Solutions, with a phone number, and the weight loss answers and the privacy policy say it fills the compounded prescriptions.Source: Omnia TeleHealth's for weight loss page; Omnia TeleHealth's privacy policy.

S4FAILNo page states that compounded products are not FDA-approved. The weight loss page offers compounded versions through the partner pharmacy beside a description of semaglutide and tirzepatide under their brand names.Source: Omnia TeleHealth's for weight loss page.

S5FAILNo certificate of analysis or lot document is published on the weight loss pages, the about page or the privacy policy.Source: Omnia TeleHealth's for weight loss page; Omnia TeleHealth's weight loss refill page; Omnia TeleHealth's about page.

S6PASS1 Spanish Main, Spanish Fort, AL, printed as the office address on the contact page, in the footer of every page and in the privacy policy, without a ZIP code.Source: Omnia TeleHealth's contact page; Omnia TeleHealth's privacy policy.

S7FAILNo medication price is printed. The weight loss consultation is a flat $69, and the answers say to contact the practice for the current price of compounded semaglutide.Source: Omnia TeleHealth's for weight loss page; Omnia TeleHealth's website.

S8PASSNo FDA warning letter names Omnia TeleHealth, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, semaglutide and tirzepatide prescriptions, female hormone replacement therapy.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit Omnia TeleHealth

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.